Cargando…

Longxuetongluo Capsule protects against cerebral ischemia/reperfusion injury through endoplasmic reticulum stress and MAPK-mediated mechanisms

INTRODUCTION: Longxuetongluo Capsule (LTC) is wildly applied to treat ischemic stroke in clinical practice in China. However, the pharmacological mechanism of LTC on ischemic stroke is still unstated. OBJECTIVE: Our research was designed to study the protective effect of LTC against cerebral ischemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Bo, Sun, Jing, Liu, Ziyu, Wang, Lingxiao, Huo, Huixia, Zhao, Yunfang, Tu, Pengfei, Xiao, Wei, Zheng, Jiao, Li, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463917/
https://www.ncbi.nlm.nih.gov/pubmed/34603791
http://dx.doi.org/10.1016/j.jare.2021.01.016
_version_ 1784572498785861632
author Pan, Bo
Sun, Jing
Liu, Ziyu
Wang, Lingxiao
Huo, Huixia
Zhao, Yunfang
Tu, Pengfei
Xiao, Wei
Zheng, Jiao
Li, Jun
author_facet Pan, Bo
Sun, Jing
Liu, Ziyu
Wang, Lingxiao
Huo, Huixia
Zhao, Yunfang
Tu, Pengfei
Xiao, Wei
Zheng, Jiao
Li, Jun
author_sort Pan, Bo
collection PubMed
description INTRODUCTION: Longxuetongluo Capsule (LTC) is wildly applied to treat ischemic stroke in clinical practice in China. However, the pharmacological mechanism of LTC on ischemic stroke is still unstated. OBJECTIVE: Our research was designed to study the protective effect of LTC against cerebral ischemia–reperfusion (I/R) injury and reveal the underlying mechanism both in vivo and in vitro. METHODS: PC12 cells treated with glucose deprivation/reperfusion (OGD/R) were used to simulate in vitro ischemia/reperfusion (I/R) injury. The cell viability, apoptosis rate, and protein expressions of PC12 cells were evaluated. In vivo validation of the protective effect of LTC was carried out by middle cerebral artery occlusion (MCAO)/reperfusion treatment, and the underlying mechanism of its anti-apoptosis ability was further revealed by immunohistochemistry staining and Western blotting. RESULTS: In the current study, we observed that LTC effectively inhibited oxygen-glucose deprivation/reperfusion (OGD/R) induced apoptosis of PC12 cells through suppressing the cleavage of poly ADP-ribose polymerase (PARP), caspase-3, and caspase-9. Further investigation revealed that OGD/R insult remarkably triggered the endoplasmic reticulum stress responses (ER stress) to induce PC12 cell apoptosis. LTC treatment alleviated OGD/R induced ER stress by inhibiting the activation of protein kinase RNA (PKR)-like ER kinase (PERK)/eukaryotic translation initiation factor 2 (eIF2α) and inositol requiring enzyme 1 (IRE1)/tumor necrosis factor receptor-associated factor 2 (TRAF2) pathways. Additionally, LTC also restrained the OGD/R-induced PC12 cell apoptosis by reversing the activated mitogen-activated protein kinase (MAPK) through IRE1/TRAF2 pathway. Animal studies demonstrated LTC significantly restricted the infarct region induced by middle cerebral artery occlusion (MCAO)/reperfusion, the activation of ER stress and apoptosis of neuronal cells had also been suppressed by LTC in the penumbra region. CONCLUSION: LTC protects the cerebral neuronal cell against ischemia/reperfusion injury through ER stress and MAPK-mediated mechanisms.
format Online
Article
Text
id pubmed-8463917
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-84639172021-10-01 Longxuetongluo Capsule protects against cerebral ischemia/reperfusion injury through endoplasmic reticulum stress and MAPK-mediated mechanisms Pan, Bo Sun, Jing Liu, Ziyu Wang, Lingxiao Huo, Huixia Zhao, Yunfang Tu, Pengfei Xiao, Wei Zheng, Jiao Li, Jun J Adv Res Pharmaceutical Science INTRODUCTION: Longxuetongluo Capsule (LTC) is wildly applied to treat ischemic stroke in clinical practice in China. However, the pharmacological mechanism of LTC on ischemic stroke is still unstated. OBJECTIVE: Our research was designed to study the protective effect of LTC against cerebral ischemia–reperfusion (I/R) injury and reveal the underlying mechanism both in vivo and in vitro. METHODS: PC12 cells treated with glucose deprivation/reperfusion (OGD/R) were used to simulate in vitro ischemia/reperfusion (I/R) injury. The cell viability, apoptosis rate, and protein expressions of PC12 cells were evaluated. In vivo validation of the protective effect of LTC was carried out by middle cerebral artery occlusion (MCAO)/reperfusion treatment, and the underlying mechanism of its anti-apoptosis ability was further revealed by immunohistochemistry staining and Western blotting. RESULTS: In the current study, we observed that LTC effectively inhibited oxygen-glucose deprivation/reperfusion (OGD/R) induced apoptosis of PC12 cells through suppressing the cleavage of poly ADP-ribose polymerase (PARP), caspase-3, and caspase-9. Further investigation revealed that OGD/R insult remarkably triggered the endoplasmic reticulum stress responses (ER stress) to induce PC12 cell apoptosis. LTC treatment alleviated OGD/R induced ER stress by inhibiting the activation of protein kinase RNA (PKR)-like ER kinase (PERK)/eukaryotic translation initiation factor 2 (eIF2α) and inositol requiring enzyme 1 (IRE1)/tumor necrosis factor receptor-associated factor 2 (TRAF2) pathways. Additionally, LTC also restrained the OGD/R-induced PC12 cell apoptosis by reversing the activated mitogen-activated protein kinase (MAPK) through IRE1/TRAF2 pathway. Animal studies demonstrated LTC significantly restricted the infarct region induced by middle cerebral artery occlusion (MCAO)/reperfusion, the activation of ER stress and apoptosis of neuronal cells had also been suppressed by LTC in the penumbra region. CONCLUSION: LTC protects the cerebral neuronal cell against ischemia/reperfusion injury through ER stress and MAPK-mediated mechanisms. Elsevier 2021-02-09 /pmc/articles/PMC8463917/ /pubmed/34603791 http://dx.doi.org/10.1016/j.jare.2021.01.016 Text en © 2021 The Authors. Published by Elsevier B.V. on behalf of Cairo University. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Pharmaceutical Science
Pan, Bo
Sun, Jing
Liu, Ziyu
Wang, Lingxiao
Huo, Huixia
Zhao, Yunfang
Tu, Pengfei
Xiao, Wei
Zheng, Jiao
Li, Jun
Longxuetongluo Capsule protects against cerebral ischemia/reperfusion injury through endoplasmic reticulum stress and MAPK-mediated mechanisms
title Longxuetongluo Capsule protects against cerebral ischemia/reperfusion injury through endoplasmic reticulum stress and MAPK-mediated mechanisms
title_full Longxuetongluo Capsule protects against cerebral ischemia/reperfusion injury through endoplasmic reticulum stress and MAPK-mediated mechanisms
title_fullStr Longxuetongluo Capsule protects against cerebral ischemia/reperfusion injury through endoplasmic reticulum stress and MAPK-mediated mechanisms
title_full_unstemmed Longxuetongluo Capsule protects against cerebral ischemia/reperfusion injury through endoplasmic reticulum stress and MAPK-mediated mechanisms
title_short Longxuetongluo Capsule protects against cerebral ischemia/reperfusion injury through endoplasmic reticulum stress and MAPK-mediated mechanisms
title_sort longxuetongluo capsule protects against cerebral ischemia/reperfusion injury through endoplasmic reticulum stress and mapk-mediated mechanisms
topic Pharmaceutical Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463917/
https://www.ncbi.nlm.nih.gov/pubmed/34603791
http://dx.doi.org/10.1016/j.jare.2021.01.016
work_keys_str_mv AT panbo longxuetongluocapsuleprotectsagainstcerebralischemiareperfusioninjurythroughendoplasmicreticulumstressandmapkmediatedmechanisms
AT sunjing longxuetongluocapsuleprotectsagainstcerebralischemiareperfusioninjurythroughendoplasmicreticulumstressandmapkmediatedmechanisms
AT liuziyu longxuetongluocapsuleprotectsagainstcerebralischemiareperfusioninjurythroughendoplasmicreticulumstressandmapkmediatedmechanisms
AT wanglingxiao longxuetongluocapsuleprotectsagainstcerebralischemiareperfusioninjurythroughendoplasmicreticulumstressandmapkmediatedmechanisms
AT huohuixia longxuetongluocapsuleprotectsagainstcerebralischemiareperfusioninjurythroughendoplasmicreticulumstressandmapkmediatedmechanisms
AT zhaoyunfang longxuetongluocapsuleprotectsagainstcerebralischemiareperfusioninjurythroughendoplasmicreticulumstressandmapkmediatedmechanisms
AT tupengfei longxuetongluocapsuleprotectsagainstcerebralischemiareperfusioninjurythroughendoplasmicreticulumstressandmapkmediatedmechanisms
AT xiaowei longxuetongluocapsuleprotectsagainstcerebralischemiareperfusioninjurythroughendoplasmicreticulumstressandmapkmediatedmechanisms
AT zhengjiao longxuetongluocapsuleprotectsagainstcerebralischemiareperfusioninjurythroughendoplasmicreticulumstressandmapkmediatedmechanisms
AT lijun longxuetongluocapsuleprotectsagainstcerebralischemiareperfusioninjurythroughendoplasmicreticulumstressandmapkmediatedmechanisms